scientifyRESEARCH
research funding database

This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.

RESEARCH FUNDING

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research Grant (Canada)

Share

Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange plus symbol appears between the two logos.
Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange play symbol appears between the two logos. An arrow mark points to the logos.

The Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada funding call from Pfizer supports Canada-based research that advances medical knowledge in the understanding, diagnosis and treatment of ATTR Amyloidosis. The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work. Applicant must be affiliated with a host institution. The grant provides 100,000 CAD (including 28% institutional overheads).

Applications are due on October 2, 2023.

Full application due:
October 2, 2023

non member

More related info for you

Register for free

Don´t have an account?

Start with our free trial to enjoy our 7 days of unlimited grant access and our premium features.

or, Choose a plan to subscribe to our premium membership.

Be the first to know

Sign-up for Personalized Grant alerts

Logo3

Sign-up for our
monthly research
funding newsletter

You can unsubscribe at any time.